Abstract
Heteroscorpine-1 (HS-1) was identified as a member of the scorpine family. HS-1 shows insecticidal activities, exhibiting a low median lethal dose (LD50) in mealworm (Tenebrio molitor L.) and inhibitory activities against Bacillus subtilis, Klebsiella pneumoniae, and Pseudomonas aeruginosa. In this study, a recombinant HS-1 (rHS-1) was produced by overexpression in E. coli. A large yield of product was obtained. The structure of purified rHS-1 was confirmed through mass spectrometry. Both anti-crude venom and anti-rHS-1 antibodies specifically recognized rHS-1, suggesting its structural similarity. Reactivated rHS-1 caused roughening and blebbing of bacterial cell surfaces. It showed higher activity than that of pre-refolded protein. Antisera raised against a partially purified and mis- or unfolded peptide can inhibit relevant bioactivity.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Many snakes inject at least 1 ml of venom in each bite, but a dose of less than 20 μl of scorpion venom will produce comparable effects on the physiology of prey and enemies. Thus, there is a high potential that scorpion venom will be a source of natural products with novel properties. Toxins are the most remarkable peptides in scorpion venoms. These toxins are mainly classified as ion channel blockers. Some toxins are predicted to have anti-microorganism and insecticidal effects (Diego-García et al. 2008; Possani et al. 1999, 2000).
The scorpines comprise a group of proteins identified as potassium channel blockers with antimicrobial activities (Conde et al. 2000; Zhu and Tytgat 2004). The first scorpine was discovered in Pandinus imperator (African emperor scorpion) venom, with inhibitory activities against Bacillus subtilis and Klebsiella pneumoniae as well as against the ookinete and gamete stages of Plasmodium berghei malaria (Conde et al. 2000). Opiscorpine, the second scorpine, is reported in African Opistophthalmus carinatus scorpion venom. It shows activity against the plant fungus Fusarium oxysporum (Zhu and Tytgat 2004). Heteroscorpine-1 (HS-1) is the next member, discovered in the venom of Heterometrus laoticus, a black giant forest scorpion most commonly found in the northeastern area of Thailand (Uawonggul et al. 2006). In terms of biological activities, native HS-1 significantly inhibits the growth of at least three types of bacteria, including B. subtilis, K. pneumoniae, and Pseudomonas aeruginosa (Uawonggul et al. 2007). However, limited availability makes further characterization impossible.
Recently, scorpion toxins have been routinely expressed in various sources, such as E. coli, yeast, and insect cell lines (Banerjee et al. 2006; Cao et al. 2003; Johnson et al. 2000; Li et al. 2006; Mao et al. 2007). Expression of these proteins with high efficiencies is useful for biochemical and pharmacological studies. We previously reported that HS-1 was the peptide identified as a K+ channel blocker. Therefore, in this study, bacterial overexpression of recombinant HS-1 (rHS-1) was successfully achieved. A plasmid with a HS-1 gene was constructed using a pGEX-6P-3 vector with the fusion part of glutathione S-transferase (GST). The rHS-1 protein was purified, reactivated, and characterized for its bioactivities. Anti-rHS-1 antibody was produced and used to neutralize the activity of crude venom.
Materials and Methods
Gene Construction
Two primers were used for the polymerase chain reaction (PCR). The forward primer (5′-GGATCCGGATGGATTAATGAAGAGAAGATACAAAAG-3′) contained a BamHI site (underlined) upstream from the Gly codon GGA. The reverse primer (5′-CTCGAGGTCCCCCTTTGGCTGCAATTA-3′) had a XhoI site (underlined) 18 residues downstream from the stop codon TAA (Fig. 1). PCR was performed with a 94°C, 5 min initial denaturing step, followed by 30 cycles of 30 s of denaturation at 94°C, 1 min of annealing at 55°C, and 1 min of elongation at 72°C. Final elongation was at 72°C for 7 min. For construction, pDrive (Qiagen) was primarily used for ligation with the 261-bp PCR products using its U overhang properties for cloning in E. coli.
Gene Expression and Purification
For expression, the pDrive vector was cut with BamHI and XhoI. The digested product was resolved by electrophoresis and further gel-purified using a gel extraction kit (Qiagen). The eluent was inserted into the pGEX-6P-3 vector (4900 bp, Pharmacia Biotech, Fig. 1), previously cut with BamHI and XhoI, resulting in a pGEX-HS-1 plasmid 5150 bp in size. The plasmid was transformed into E. coli JM109 competent cells. After overnight incubation, a single colony from a transformation plate was inoculated in 20 ml LB broth with ampicillin selection. After shaking at 120 rpm at 28°C overnight, a second inoculation for medium-scale preparation was started using 500 ml of cells with an OD600 of approximately 0.05. After shaking at 37°C at a rate of 250 rpm, until the OD600 had reached 0.5–0.6, cells were induced by the addition of 0.2 mM isopropyl β-D-thiogalactopyranoside (IPTG) followed by continuous agitation at 210 rpm for 5 h at 37°C. Cells were pelleted by centrifugation at 4000g for 10 min at 4°C. The pellet was washed in 10 ml sonication buffer (50 mM sodium phosphate pH 7.8 and 300 mM NaCl) and spun at 4000g for 4 min at 4°C. The cell pellet was collected and washed in 10 ml precooled NETN buffer (100 mM NaCl, 20 mM Tris–HCl pH 8.0, 1 mM EDTA, and 2% NP-40) and disrupted by sonication on ice. After centrifugation at 10,000g for 20 min at 4°C, the supernatant was incubated with 1 ml of 50% slurry glutathione–Sepharose 4B beads (GE Healthcare) at 4°C with rocking for 60 min to purify the recombinant protein. Beads with immobilized recombinant protein were washed with 20 ml NETN buffer. The matrix was then washed and equilibrated with 10 volumes (10 ml) of cleavage buffer (50 mM Tris–HCl pH 7.2, 150 mM NaCl, 1 mM EDTA, and 1 mM dithiothreitol) at 5°C. After removing the residual buffer, the GST tag was cleaved from the fusion protein using 80 U/ml PreScission Protease (GE Healthcare) in 1 ml bead slurry in 100 μl cleavage buffer with gentle suspension at 5°C for 4 h. The beads were briefly spun (500g, 5 min), and the supernatant containing recombinant protein was collected. GST and GST-uncut protein were removed by repeated incubation with glutathione–Sepharose beads. Protein purity was finally evaluated by subjecting 5 μl of solution to Tris-tricine sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE).
Tris-tricine SDS-PAGE
The method used here followed a published protocol (Schagger and von Jagow 1987) with slight modification. Samples were mixed with an equal volume of 2× SDS sample buffer (125 mM Tris pH 6.8, 25% glycerol, 4% SDS, 0.008% BPB, and 10% 2-mercaptoethanol). Before resolving at 90 V, the upper reservoir was filled with cathode buffer pH 8.5 (100 mM Tris, 100 mM tricine, and 0.1% SDS), and the lower with the anode buffer (200 mM Tris pH 8.8).
Two-Dimensional PAGE
Immobilized pH gradient (IPG)-SDS-PAGE was performed as previously described (Prajanban et al. 2012). The sample was separated in the first dimension on a 7 cm immobilized pH gradient strip (pH 3–11). Then, the strip was rehydrated for 12 h and focused for 9250 total V × h using the Ettan IPGphor (GE Healthcare Bio-Sciences). Next, the strip was washed in SDS equilibration buffer (50 mM Tris–HCl pH 8.8, 6 M urea, 30% glycerol, 2% SDS, and 0.002% bromophenol blue) containing 2% dithiothreitol followed by a buffer containing 5% iodoacetamide. The second resolution dimension consisted of 15% SDS-PAGE. Proteins were stained with Coomassie Brilliant Blue G-250. Excised spots were analyzed for their peptide mass fingerprints using matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometry at the Genome Institute, National Science and Technology Development Agency, Pathumthani, Thailand.
Refolding Process
Samples were resuspended in denaturation buffer (50 mM Tris–HCl pH 8.0, 5 M guanidine HCl, and 5 mM EDTA) and incubated on ice for 1 h (Junn et al. 2005). The protein solubilized in the denaturation buffer was slowly diluted 1:10 using renaturation buffer (50 mM Tris–HCl pH 8.0, 1% Triton X-100, 8 mM reduced glutathione (GSH), 1 mM oxidized glutathione (GSSG), 0.5 mM PMSF, and 0.3 M arginine). The soluble fractions were then desalted using a PD-10 desalting column (GE Healthcare). Proteins were separated by 16.5% Tris-tricine SDS-PAGE.
Antibacterial Assay and Scanning Electron Microscopy
Diameters of inhibition zones were measured after employing the disc diffusion method using Mueller–Hinton agar plates at 37°C (Uawonggul et al. 2007). Bacterial cells from the inhibition zone were fixed in 2.5% glutaraldehyde overnight before coating with gold and observing under scanning electron microscope (LEO 1450VP, LEO Electron Microscope).
Cross-reactivity
Mice were subcutaneously injected with antigen previously mixed with complete Freund’s adjuvant at 1:1 (v/v). Boosts were mixed with antigen at 1:1 (v/v) with incomplete Freund’s adjuvant at 2-week intervals. Three days after the fourth boost, antiserum was analyzed via ELISA and Western immunoblotting. For ELISA, immobilized antigen on a polystyrene plate was incubated with antiserum and detected indirectly with alkali phosphatase-conjugated anti-mouse IgG antibody. The substrate in the final step was p-nitrophenyl phosphate with 405 nm spectroscopic detection. For Western immunoblotting, proteins separated by SDS-PAGE were transferred to nitrocellulose membranes. The resulting antigen on the membrane was incubated with antiserum and alkali phosphatase-conjugated anti-mouse IgG antibody. A substrate kit was used to detect the resulting bands.
Bioassay and Neutralization Assay
The median lethal dose (LD50) of rHS-1 was determined by sample injection into mealworms (Tenebrio molitor L., 0.10 ± 0.01 g body weight). Control animals were injected with PBS buffer, pH 7.4. Those without any movement after 30 min of injection were considered dead. For the antibody neutralization assay, the median paralytic dose (PD50) was detected in crickets (Gryllus sp., 0.30 ± 0.03 g body weight). Ten microliters of the respective solution, venom and venom pretreated with anti-crude venom and anti-rHS-1 antibodies, was injected in animals abdominally. Crude venom incubated with anti-Vibrio Ogawa antibody was used as a control. Venom-injected crickets that could not turn over from a dorsal-upright position within 10 min were considered to be paralyzed.
Results
HS-1 Gene Characterization
A previous study discovered the partial amino acid sequence of native HS-1 by MALDI-TOF tandem mass spectroscopy analysis, revealing a high similarity score to scorpine (Uawonggul et al. 2007). Consecutive rounds of PCR using genomic DNA as a template with seven pairs of generated and nongenerated primers, designed from scorpine family sequences, revealed the full sequence of the HS-1 gene (accession no. P0C2F4 = protein name > sp|P0C2F4|). After deduction, 76 amino acid residues were present in the mature protein, with Gly as the first. Three disulfide bonds consisting of six cysteine residues were programmatically predicted, similar to other scorpine protein family members (Zhu and Tytgat 2004). No significant difference between the mass theoretically determined (8293.07 Da) and empirically determined mass by mass spectrometry (8293.496 Da) was observed, suggesting no additions, deletions, or any post-expression processes affected the primary structure.
HS-1 Gene Expression and Purification
Following protein expression resulting from IPTG induction, whole-cell lysates were resolved in Tris-tricine SDS-PAGE, and one major band at approximately 34 kDa clearly appeared (Fig. 2). This band size corresponded to the expected size of GST-HS-1 recombinant protein. Recombinant protein was then cut with PreScission Protease and purified, and a single band of purified rHS-1 protein at approximately 8.3 kDa was obtained (Fig. 3). Protein quantitation using Bradford dye staining indicated a protein concentration of 1 μg/μl. Ultimately, 200 μg of HS-1 per 500 ml initial growth was obtained, suggesting a large amount of HS-1 protein expression throughout the procedure. Fortunately, the expression product was completely soluble in aqueous solution, and no inclusion bodies were detected.
Reactivation of rHS-1
Since the soluble rHS-1 was not correctly folded to obtain bioactivity from this peptide, a refolding method was performed using the reduced and oxidized glutathione system. After slow exposure to glutathione and removal of contaminants by dialysis, SDS-PAGE showed refolded HS-1 as a major band at approximately 8 kDa, in agreement with that of rHS-1 (Fig. 4). An evaluation for immunological reactivity revealed that anti-crude venom and anti-rHS-1 antibodies specifically recognized the refolded HS-1 (Fig. 5), suggesting that no significant structural changes occurred during the refolding process. However, a poor recovery (less than 1 μg) of refolded HS-1 was obtained from an initial 200 μg of rHS-1.
However, refolded rHS-1 seemed to have activity. For insecticidal activity, the LD50 of refolded HS-1 was approximately 52 μg/g body weight of mealworm, significantly lower in value (higher in activity) than that of the pre-refolded protein (Table 1). The refolded protein also exhibited clear zones of inhibition when exposed to the three types of HS-1-susceptible bacteria (Table 2).
Recombinant HS-1 Identification and Characterization
A proteomic approach was used to verify purified rHS-1. After being subjected to 2D-PAGE, a major spot corresponding to HS-1 was analyzed (Fig. 6). Peptide mass fingerprinting of that protein revealed three peptides corresponding to a partial HS-1 sequence covering around 52% of the mature protein (Table 3). Two sequences, KIDEKIGNNILGGMAKA and KGEFQCVANIDTMGNCETHCQKT, collectively represent 40 of the 76 residues of the full-length mature sequence. This result indicated that rHS-1 and HS-1 were the same protein.
Cross-reactions of Recombinant HS-1
To determine cross-reactivity of rHS-1 with native HS-1, anti-crude venom and anti-rHS-1 antibodies were produced by subcutaneous injection of either scorpion crude venom or purified rHS-1 into mice. ELISA showed that the antibodies had titres of 1:104 against their antigens. Western immunoblotting revealed the specificity of the antibodies to their antigens (Fig. 5). rHS-1 was recognized by both antibodies (Fig. 5). It is interesting that anti-rHS-1 and anti-crude venom antibodies specifically bound to native HS-1 in scorpion crude venom and refolded HS-1, respectively (Fig. 5). These results suggest that the epitopes of the native and the recombinant proteins are still conserved.
Effects of Recombinant HS-1 on Bacterial Cell Morphology
Anti-microorganism peptides normally act by affecting bacterial cell walls (Pata et al. 2011). The cellular morphologies of B. subtilis, K. pneumoniae, and P. aeruginosa were examined by scanning electron microscopy following treatment with crude venom or refolded HS-1 (Fig. 7). Untreated bacterial cells had normal and smooth cell surfaces. In contrast, such bacterial cells treated with crude venom and refolded HS-1 showed apparent changes in their morphology. Roughening and blebbing of the bacterial surfaces were both readily observable.
Antibody-Mediated Neutralization of Venom Toxicity
The possibility of neutralizing the toxicity of crude scorpion venom by anti-rHS-1 antibody was investigated by PD50 determination in crickets (Table 4). A significant increase in the PD50 value of crude venom was observed (34.00 μg/g body weight) after animals were exposed to crude venom pretreated with anti-rHS-1 antibody, compared with those injected with untreated crude venom (11.13 μg/g body weight) or control antibody (anti-Vibrio Ogawa antibody, 11.40 μg/g body weight). This result suggests that the antibody was able to neutralize the toxic effects of crude scorpion venom. Therefore, anti-rHS-1 antibody may have broader implications, such as in the development of antivenom.
Discussion
This study outlines the preparation of HS-1 on a large scale and introduces two points of interest: (1) reactivated rHS-1 may be used for therapeutic purposes, especially for its antimicrobial activity, and (2) an antibody against nontoxic (unfolded) rHS-1 may be employed for antivenom production in the future.
Although one member of the scorpine protein family has been successfully expressed in a eukaryotic system with the intention of being expressed in the targeted host (Anopheles gambiae cells), no overexpression was obtained in the host (Carballar-Lejarazú et al. 2008). As potent antiplasmodial peptides, scorpines have been expressed in entomophatogenic fungi (Fang et al. 2011) or symbiotic bacteria (Wang et al. 2012). A recombinant scorpine-like peptide, Ev37, has been reported to block the kv1.3 channel without cytolytic activity (Feng et al. 2013). Expression of HS-1 in this study, however, showed at least two unique characteristics when compared with other scorpine family members: no inclusion bodies were detected, and the recombinant protein was able to recover its activity in just one iteration of the GSH/GSSG refolding process.
Technically, the yield of HS-1 decreased after induction for more than 5 h (data not shown), similar to the expression of BmTXKβ in E. coli (Cao et al. 2003). Extended periods of induction of BmTXKβ at high temperatures cause a reduction in expression yield, suggesting that the recombinant fusion protein in the bacterial cytoplasm or in the medium is degraded by intracellular enzymes. BmTXKβ was finally successfully expressed in E. coli at 30°C, whereas E. coli containing the hs-1 gene grew slower at 30°C than 37°C, causing slower induction (Guatimosim et al. 2000). Furthermore, fusion HS-1 was cut before being purified. The cleavage enzyme, PreScission Protease, was never directly removed; however, no contaminant bands appeared upon SDS-PAGE analysis, indicating that the protease has no significant impact in any other assays or characterizations in further steps.
Although the mass fingerprint result from mass spectrometry helped to confirm the identity of rHS-1, the rHS-1 completely lost activity. The PD50 value was relatively high in an insecticidal assay. This result is not entirely surprising, as gene expression of eukaryotic products in a prokaryotic system always encounters the problem of improper post-translational modifications, especially disulfide bond misformation (Johnson et al. 2000), resulting in defective conformational changes. HS-1 contains three predicted disulfide bridges involving six cysteine residues toward the C terminus (Uawonggul et al. 2007). For recombinant CssII, eight cysteines compose four disulfide bridges. The number of possible structures is 105, whereas the number for HS-1 is 15, with a relatively lower possibility of structural variation. Thus, HS-1 showed a tendency to be easier to recover.
A reduced and oxidized glutathione system was selected for the refolding procedure in a suitable buffer to recover HS-1 activity. This system is believed to promote disulfide bond formation by NADPH-mediated GSH/GSSG intercalation. HS-1 activity was apparently recovered by this process. The rHS-1 as well as the refolded rHS-1 ran to the same position in SDS-PAGE analysis. Cross-reactions using antibodies against crude venom and refolded rHS-1 were observed. Both antibodies perfectly recognized HS-1, suggesting no major changes in its epitope structures. Refolded HS-1 showed activity in mealworms, crickets, and bacteria, although that activity was less than that of crude venom. Bacteria treated with crude venom or refolded HS-1 exhibited blebbing in the cell membrane, in agreement with the unusual bacterial cell membrane morphology observed previously (Uawonggul et al. 2007). These results confirm that the refolding process recovers the rHS-1 activity. The three-dimensional conformation of rHS-1 might change after the refolding process, which may affect its antimicrobial activity, possibly mediated by the carboxyl-terminal segment composed of the typical Cys pattern of invertebrate defensin (Zhu and Tytgat 2004). Refolded HS-1, however, exhibited lower activities than previously reported for purified HS-1 (Uawonggul et al. 2007), suggesting that rHS-1 molecules were only partially structurally recovered (Estrada et al. 2007). The anti-rHS-1 antibody was able to neutralize the toxicity of crude venom. This implied the cross-reactivity of anti-rHS-1 antibody with native HS-1, confirming that they have similar structures (at least at the primary structure level). The folding of their structures at higher levels (secondary and/or tertiary structures) may be different.
Recent proteomic and transcriptomic analysis has revealed that scorpion venoms are composed of dozens or even hundreds of distinct protein components (Rodriguez de la Vega et al. 2010). In H. laoticus venom, the 2D-PAGE profile with Coomassie Brilliant Blue staining revealed at least 50 spots (Incamnoi et al. 2013). Though crude venom is clearly composed of many active components, neutralization of only HS-1 was able to reduce total venom activity by nearly one-third {1 − [(92.50 − 34.00)/92.50] = 0.37} (Table 4). This result corresponds to that of Pg8 expression, the toxin from the scorpion Parabuthus granulates (García-Gómez et al. 2009). When recombinant Pg8 was used for immunization, its antiserum completely neutralized Pg8’s toxic effect. In that instance, only one component in the venom was inhibited by antibody conjugation, but the toxicity of the venom was significantly reduced. This suggests that HS-1 may contribute the majority of scorpion venom’s toxicity, as well.
This study presents a solution to at least four of these challenges: (1) rHS-1 was produced by overexpression without any toxic effects to bacterial cells. There was no stop or delay during expression, and a large yield of product was obtained. (2) Anti-HS-1 antibody shows high neutralizing efficiency against crude venom by reducing the LD50 value by one-third, while the anti-crude venom antibody displayed little effect on the LD50 value. An antibody against this one component is predicted to reduce symptoms of scorpion envenomation significantly. (3) An antiserum raised against a partially purified and mis- or unfolded peptide can actually inhibit a relevant bioactivity (the paralysis assays). (4) Allergenic reactions among scorpion victims are predicted to be lower after treatment with anti-rHS-1 antiserum than with anti-crude venom antibody or any antibody cocktails currently used because the number of antigenic determinants (epitopes) of HS-1 must be much less than those of crude venom. These findings may aid in antivenom production, which has emerged as a major need, especially in Third World countries where scorpion envenomation remains a serious health problem.
References
Banerjee S, Curto EV, Beckman M, Brown GB, Zhong J, Kirshna R (2006) Expression of functional scorpion neurotoxin Lqq-V in E. coli. Peptides 27:49–54
Cao Z, Xiao F, Peng F, Jiang D, Mao X, Liu H, Li W, Hu D, Wang T (2003) Expression, purification and functional characterization of a recombinant scorpion venom peptide BmTXKβ. Peptides 24:187–192
Carballar-Lejarazú R, Rodríguez MH, de la Hernández-Hernández Cruz F, Ramos-Castañeda J, Possani LD, Zurita-Ortega M, Reynaud-Garza E, Hernández-Rivas R, Loukeris T, Lycett G, Lanz-Mendoza H (2008) Recombinant scorpine: a multifunctional antimicrobial peptide with activity against different pathogens. Cell Mol Life Sci 65:3081–3092
Conde R, Zamudio FZ, Rodriguez MH, Possani LD (2000) Scorpine, an anti-malaria and anti-bacterial agent purified from scorpion venom. FEBS Lett 471:165–168
Diego-García E, Abdel-Mottaleb Y, Schwartz EF, de la Vega RC, Tytgat J, Possani LD (2008) Cytolytic and K+ channel blocking activities of beta-KTx and scorpine-like peptides purified from scorpion venoms. Cell Mol Life Sci 65:187–200
Estrada G, Garcia BI, Sciavon E, Ortiz E, Cestele S, Wanke E, Possani LD, Corzo G (2007) Four disulfide-bridged scorpion beta neurotoxin CssII: heterologous expression and proper folding in vitro. Biochim Biophys Acta 1770:1161–1168
Fang W, Vega-Rodríguez J, Ghosh AK, Jacobs-Lorena M, Kang A, St. Leger RJ (2011) Development of transgenic fungi that kill human malaria parasites in mosquitoes. Science 331:1074–1077
Feng J, Yu C, Wang M, Li Z, Wu Y, Cao Z, Li W, He X, Han S (2013) Expression and characterization of a novel scorpine-like peptide Ev37, from the scorpion Euscorpiops validus. Protein Expr Purif 88:127–133
García-Gómez BI, Olamendi-Portugal TC, Paniagua J, van der Walt J, Dyason K, Possani LD (2009) Heterologous expression of a gene that codes for Pg8, a scorpion toxin of Parabuthus granulatus, capable of generating protecting antibodies in mice. Toxicon 53:770–778
Guatimosim SCF, Kalapothakis E, Diniz CR, Chávez-Olórtegui C (2000) Induction of neutralizing antibodies against Tityus serrulatus toxins by immunization with a recombinant nontoxic protein. Toxicon 38:113–121
Incamnoi P, Patramanon R, Thammasirirak S, Chaveerach A, Uawonggul N, Sukprasert S, Rungsa P, Daduang J, Daduang S (2013) Heteromtoxin (HmTx), a novel heterodimeric phospholipase A2 from Heterometrus laoticus scorpion venom. Toxicon 61:62–71
Johnson TM, Quick MW, Sakai TT, Rama Krishna N (2000) Expression of functional recombinant scorpion β-neurotoxin Css II in E. Coli. Peptides 21:767–772
Junn HJ, Youn K, Suh HK, Lee SS (2005) Cloning and expression of Klebsiella phage K11 lysozyme gene. Protein Expr Purif 42:78–84
Li C, Zhang J, Yang B, Jiao J, Wang L, Wu C (2006) ANEPIII, a new recombinant neurotoxic polypeptide derived from scorpion peptide, inhibits delayed rectifier, but not A-type potassium currents in rat primary cultured hippocampal and cortical neurons. Regul Pept 133:74–81
Mao X, Cao Z, Yin S, Ma Y, Wu Y, Li W (2007) Cloning and characterization of BmK86, a novel K+-channel blocker from scorpion venom. Biochem Biophys Res Commun 360:728–734
Pata S, Yaraksa N, Daduang S, Temsiripong Y, Svasti J, Araki T, Thammasirirak S (2011) Characterization of the novel antibacterial peptide Leucrocin from crocodile (Crocodylus siamensis) white blood cell extracts. Dev Comp Immunol 35:545–553
Possani LD, Becerril B, Delepierre M, Tytgat J (1999) Scorpion toxins specific for Na+-channels. Eur J Biochem 264:287–300
Possani LD, Merino E, Corona M, Bolivar F, Becerril B (2000) Peptides and genes coding for scorpion toxins that affect ion-channels. Biochimie 82:861–868
Prajanban BO, Shawsuan L, Daduang S, Kommanee J, Roytrakul S, Dhiravisit A, Thammasirirak S (2012) Identification of five reptile egg white proteins using MALDI-TOF mass spectrometry and LC/MS–MS analysis. J Proteomics 75:1940–1959
Rodriguez de la Vega RC, Schwartz EF, Possani LD (2010) Mining on scorpion venom biodiversity. Toxicon 56:1155–1161
Schagger H, von Jagow G (1987) Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem 166:368–379
Uawonggul N, Chaveerach A, Thammasirirak S, Arkaravichien T, Chuachan C, Daduang S (2006) Screening of plants acting against Heterometrus laoticus scorpion venom activity on fibroblast cell lysis. J Ethnopharmacol 103:201–207
Uawonggul N, Thammasirirak S, Chaveerach A, Arkaravichien T, Bunyatratchata W, Ruangjirachuporn W, Jearranaiprepame P, Nakamura T, Matsuda M, Kobayashi M, Hattori S, Daduang S (2007) Purification and characterization of heteroscorpine-1 (HS-1) toxin from Heterometrus laoticus scorpion venom. Toxicon 49:19–29
Wang S, Ghosh AK, Bongio N, Stebbings KA, Lampe DJ, Jacobs-Lorena M (2012) Fighting malaria with engineered symbiotic bacteria from vector mosquitoes. PNAS www.pnas.org/cgi/doi/10.1073/pnas.1204158109
Zhu S, Tytgat J (2004) The scorpine family of defensins: gene structure, alternative polyadenylation and fold recognition. Cell Mol Life Sci 61:1751–1763
Acknowledgments
This work was supported by the Japan Society for the Promotion of Science (JSPS) and the TRF-CHE Research Grant for Mid-Career University Faculty; jointly funded by the Thailand Research Fund (TRF) and the Office of the Higher Education Commission (CHE), Ministry of Education, Thailand; and additionally supported by the Khon Kaen University (KKU) Research Fund, fiscal years 2006–2010. This research was also supported by a grant from the Strategic Scholarships for Frontier Research Network for the Thai Postdoctoral Programs to N.U. from CHE and Synchrotron Light Research Institute (SLRI), Thailand, grant number 2552/07. We would like to thank Prof. Yukifumi Nawa of the KKU Publication Clinic for critical reading of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Uawonggul, N., Sukprasert, S., Incamnoi, P. et al. Bacterial Overexpression of Recombinant Heteroscorpine-1 (rHS-1), a Toxin from Heterometrus laoticus Scorpion Venom: Trends for Antibacterial Application and Antivenom Production. Biochem Genet 52, 459–473 (2014). https://doi.org/10.1007/s10528-014-9660-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10528-014-9660-y